MRX
MRX
Marex Group plc Ordinary SharesIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $500.1M ▼ | $93.4M ▼ | $76.7M ▼ | 15.34% ▲ | $2.01 ▲ | $109.4M ▼ |
| Q4-2024 | $2.15B ▲ | $159.8M ▼ | $115.1M ▲ | 5.34% ▼ | $1.54 ▲ | $450.5M ▲ |
| Q2-2024 | $740M ▲ | $291.1M ▼ | $102.9M ▲ | 13.91% ▲ | $1.33 ▲ | $406.6M ▲ |
| Q4-2023 | $720.7M ▼ | $837.4M ▼ | $50.5M ▼ | 7.01% ▼ | $0.72 ▼ | $-118.7M ▼ |
| Q2-2023 | $1.16B | $1.15B | $90.8M | 7.82% | $1.28 | $110.9M |
What's going well?
The company stayed profitable despite a massive revenue drop. Interest expenses disappeared this quarter, which helped keep the bottom line positive.
What's concerning?
Revenue and operating profit both fell sharply, raising questions about the company's ability to sustain its business. The drop in sales far outpaced any cost savings, and efficiency is slipping.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $6.91B ▲ | $31.19B ▲ | $30.08B ▲ | $1.11B ▲ |
| Q4-2024 | $5.21B ▲ | $24.31B ▲ | $23.34B ▲ | $976.9M ▲ |
| Q2-2024 | $4.45B ▼ | $17.19B ▼ | $16.31B ▼ | $882.3M ▲ |
| Q4-2023 | $4.73B ▲ | $17.61B ▲ | $16.84B ▲ | $775.9M ▲ |
| Q2-2023 | $1.65B | $16.3B | $15.57B | $735.2M |
What's financially strong about this company?
MRX boosted its cash and investments to $15.4B, giving it flexibility. Most assets are liquid, and there's little exposure to goodwill or inventory risks.
What are the financial risks or weaknesses?
Debt and payables jumped sharply, now dwarfing equity. The company is highly leveraged, and working capital is under pressure from slow customer payments and delayed supplier payments.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $149.2M ▲ | $927.7M ▲ | $-68.1M ▼ | $-80.4M ▼ | $3.38B ▲ | $918.9M ▲ |
| Q4-2024 | $115.1M ▲ | $711M ▲ | $-24.6M ▼ | $-33.4M ▼ | $865.6M ▲ | $704.6M ▲ |
| Q2-2024 | $102.9M ▲ | $452.5M ▲ | $-10.7M ▲ | $-3.8M ▲ | $438M ▼ | $443.3M ▲ |
| Q4-2023 | $70.65M | $367.5M | $-48.8M | $-36.4M | $573.4M | $361.45M |
| Q2-2023 | $70.65M | $367.5M | $-48.8M | $-36.4M | $573.4M | $361.45M |
What's strong about this company's cash flow?
MRX is consistently generating strong cash from its core business, with free cash flow rising to $919 million. The company is self-funding, paying down debt, and returning cash to shareholders through dividends and buybacks.
What are the cash flow concerns?
A large increase in receivables and inventory is tying up cash, which could signal slower customer payments or potential sales issues. If this trend continues, it could eventually pressure cash flow.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Marex Group plc Ordinary Shares's financial evolution and strategic trajectory over the past five years.
MRX combines strong top-line growth with improving profitability, robust operating and free cash flow, and a diversified, mostly agency-focused business model. Its proprietary technology platforms and deep commodities, clearing, and structured products expertise create meaningful client stickiness. The balance sheet, while more leveraged, now holds substantially more assets and cash, and retained earnings are building steadily. Management has shown an ability to grow both organically and through acquisitions while increasingly returning cash to shareholders.
The most notable financial risk is high leverage, which has risen sharply and drives growing interest expenses and reliance on steady funding access. Liquidity, while improved, remains tight and must be carefully managed given large short-term obligations. Operationally, MRX faces intense competition, regulatory and market-structure risk, and the complexities of integrating acquisitions. Volatile working capital, particularly in receivables, and the push into newer areas such as digital assets and a 24/7 model add execution and compliance uncertainties.
Overall, MRX looks like a high-growth, cash-generative capital-markets platform with a strong technology backbone and expanding global footprint. If it can continue to manage leverage prudently, maintain liquidity, and execute on its innovation and acquisition agenda without major missteps, its diversified model and proprietary platforms position it well to benefit from ongoing growth in derivatives, structured products, and specialized financial services. Outcomes will be highly sensitive to market conditions, regulatory developments, and the firm’s ability to balance expansion with conservative risk and balance sheet management.
About Marex Group plc Ordinary Shares
https://www.marex.comMarex Group plc, a financial services platform provider company, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $500.1M ▼ | $93.4M ▼ | $76.7M ▼ | 15.34% ▲ | $2.01 ▲ | $109.4M ▼ |
| Q4-2024 | $2.15B ▲ | $159.8M ▼ | $115.1M ▲ | 5.34% ▼ | $1.54 ▲ | $450.5M ▲ |
| Q2-2024 | $740M ▲ | $291.1M ▼ | $102.9M ▲ | 13.91% ▲ | $1.33 ▲ | $406.6M ▲ |
| Q4-2023 | $720.7M ▼ | $837.4M ▼ | $50.5M ▼ | 7.01% ▼ | $0.72 ▼ | $-118.7M ▼ |
| Q2-2023 | $1.16B | $1.15B | $90.8M | 7.82% | $1.28 | $110.9M |
What's going well?
The company stayed profitable despite a massive revenue drop. Interest expenses disappeared this quarter, which helped keep the bottom line positive.
What's concerning?
Revenue and operating profit both fell sharply, raising questions about the company's ability to sustain its business. The drop in sales far outpaced any cost savings, and efficiency is slipping.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $6.91B ▲ | $31.19B ▲ | $30.08B ▲ | $1.11B ▲ |
| Q4-2024 | $5.21B ▲ | $24.31B ▲ | $23.34B ▲ | $976.9M ▲ |
| Q2-2024 | $4.45B ▼ | $17.19B ▼ | $16.31B ▼ | $882.3M ▲ |
| Q4-2023 | $4.73B ▲ | $17.61B ▲ | $16.84B ▲ | $775.9M ▲ |
| Q2-2023 | $1.65B | $16.3B | $15.57B | $735.2M |
What's financially strong about this company?
MRX boosted its cash and investments to $15.4B, giving it flexibility. Most assets are liquid, and there's little exposure to goodwill or inventory risks.
What are the financial risks or weaknesses?
Debt and payables jumped sharply, now dwarfing equity. The company is highly leveraged, and working capital is under pressure from slow customer payments and delayed supplier payments.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $149.2M ▲ | $927.7M ▲ | $-68.1M ▼ | $-80.4M ▼ | $3.38B ▲ | $918.9M ▲ |
| Q4-2024 | $115.1M ▲ | $711M ▲ | $-24.6M ▼ | $-33.4M ▼ | $865.6M ▲ | $704.6M ▲ |
| Q2-2024 | $102.9M ▲ | $452.5M ▲ | $-10.7M ▲ | $-3.8M ▲ | $438M ▼ | $443.3M ▲ |
| Q4-2023 | $70.65M | $367.5M | $-48.8M | $-36.4M | $573.4M | $361.45M |
| Q2-2023 | $70.65M | $367.5M | $-48.8M | $-36.4M | $573.4M | $361.45M |
What's strong about this company's cash flow?
MRX is consistently generating strong cash from its core business, with free cash flow rising to $919 million. The company is self-funding, paying down debt, and returning cash to shareholders through dividends and buybacks.
What are the cash flow concerns?
A large increase in receivables and inventory is tying up cash, which could signal slower customer payments or potential sales issues. If this trend continues, it could eventually pressure cash flow.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Marex Group plc Ordinary Shares's financial evolution and strategic trajectory over the past five years.
MRX combines strong top-line growth with improving profitability, robust operating and free cash flow, and a diversified, mostly agency-focused business model. Its proprietary technology platforms and deep commodities, clearing, and structured products expertise create meaningful client stickiness. The balance sheet, while more leveraged, now holds substantially more assets and cash, and retained earnings are building steadily. Management has shown an ability to grow both organically and through acquisitions while increasingly returning cash to shareholders.
The most notable financial risk is high leverage, which has risen sharply and drives growing interest expenses and reliance on steady funding access. Liquidity, while improved, remains tight and must be carefully managed given large short-term obligations. Operationally, MRX faces intense competition, regulatory and market-structure risk, and the complexities of integrating acquisitions. Volatile working capital, particularly in receivables, and the push into newer areas such as digital assets and a 24/7 model add execution and compliance uncertainties.
Overall, MRX looks like a high-growth, cash-generative capital-markets platform with a strong technology backbone and expanding global footprint. If it can continue to manage leverage prudently, maintain liquidity, and execute on its innovation and acquisition agenda without major missteps, its diversified model and proprietary platforms position it well to benefit from ongoing growth in derivatives, structured products, and specialized financial services. Outcomes will be highly sensitive to market conditions, regulatory developments, and the firm’s ability to balance expansion with conservative risk and balance sheet management.

CEO
Ian Theo Lowitt
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 46
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
TD Cowen
Buy
Piper Sandler
Overweight
Barclays
Overweight
Goldman Sachs
Buy
Keefe, Bruyette & Woods
Outperform
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:3.97M
Value:$172.39M
CAPITAL INTERNATIONAL INVESTORS
Shares:3.49M
Value:$151.59M
LOOMIS SAYLES & CO L P
Shares:1.94M
Value:$84.12M
Summary
Showing Top 3 of 249

